These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6764078)

  • 21. [Plasmapheresis efficacy in the treatment of patients with chronic cholestatic hepatitis and primary biliary liver cirrhosis].
    Radchenko VG
    Lik Sprava; 1995; (5-6):160-3. PubMed ID: 8630792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Disorders of albumin metabolism in chronic cholestatic hepatitis].
    Vinogradov VA; Podymova SD
    Sov Med; 1975 Feb; (2):21-6. PubMed ID: 1145273
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of methotrexate in the treatment of chronic cholestatic disorders.
    Novak K; Swain MG
    Clin Liver Dis; 2008 Feb; 12(1):81-96, viii. PubMed ID: 18242498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acholangic cholestatic hepatitis evolving towards xanthomatosis and cirrhosis].
    Caroli J; Nusinovici V; Amar AB; Lévy VG
    Ann Med Interne (Paris); 1973 Nov; 124(11):761-70. PubMed ID: 4792229
    [No Abstract]   [Full Text] [Related]  

  • 25. [For which liver diseases is immunosuppressive therapy indicated?].
    Bannaski H
    Med Klin Prax; 1982 Aug; 77(16-17):66-71, 74. PubMed ID: 7132889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [DIC in diseases of the liver and biliary tract (author's transl)].
    Fukui H; Tsujii T; Matsuyama Y
    Rinsho Byori; 1978 Oct; 26(10):817-24. PubMed ID: 713082
    [No Abstract]   [Full Text] [Related]  

  • 27. [Combined form of chronic aggressive hepatitis primary biliary cirrhosis].
    Zimmermann K; Cueni B; Schmid M
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1749-52. PubMed ID: 929135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppressive therapy in chronic liver disease.
    Sherlock S
    Minerva Med; 1978 Aug; 69(38):2605-9. PubMed ID: 714260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.
    Makino I; Nakagawa S; Mashimo K
    Gastroenterology; 1969 Jun; 56(6):1033-9. PubMed ID: 5788911
    [No Abstract]   [Full Text] [Related]  

  • 30. Advances in the therapy of cholestatic liver disease.
    Roda E; Parini P; Bazzoli F; Mazzella G; Festi D; Aldini R
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():53-5. PubMed ID: 1577396
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinico-morphological dynamics of chronic diffuse liver diseases].
    Loginov AS; Blok IuE; Shepeleva SD; Tkachev VD
    Ter Arkh; 1981; 53(11):50-9. PubMed ID: 7339906
    [No Abstract]   [Full Text] [Related]  

  • 32. [Long-term therapy of liver diseases].
    Renger F; Dökert B
    Z Gesamte Inn Med; 1973 Jun; 28(11):Suppl:165-8. PubMed ID: 4728085
    [No Abstract]   [Full Text] [Related]  

  • 33. [Cholestatic cirrhosis caused by lithiasic retention jaundice. Course of biliary and hepatic functions after operation].
    Langeron P; Sigam M; Puppinck P
    Lille Med; 1971 Mar; 16(3):437-41. PubMed ID: 5566806
    [No Abstract]   [Full Text] [Related]  

  • 34. The problem of hepatitis.
    Popper H
    Am J Gastroenterol; 1971 Apr; 55(4):335-46. PubMed ID: 4935685
    [No Abstract]   [Full Text] [Related]  

  • 35. [Primary biliary cirrhosis and medical treatment of cholestasis].
    Stave R
    Tidsskr Nor Laegeforen; 1975 Feb; 95(5):296-8. PubMed ID: 1118851
    [No Abstract]   [Full Text] [Related]  

  • 36. [The liver-colitis syndrome].
    Kaiser C
    Gastroenterologia; 1966; 105(6):335-50. PubMed ID: 5958597
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum bile acids and rountine liver function tests in patients with chronic liver disease and cholestasis.
    Collins DM; Tongeren AV; Cook HB; Campbell CB
    N Z Med J; 1979 Jun; 89(637):432-4. PubMed ID: 289016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic active (aggressive) hepatitis. Differential diagnosis of lupoid (ANA-positive) and cholestatic (AMA-positive) hepatitis].
    Berg PA
    Dtsch Med Wochenschr; 1976 Oct; 101(42):1536-43. PubMed ID: 789040
    [No Abstract]   [Full Text] [Related]  

  • 39. Intrahepatic cholestasis in common chronic liver diseases.
    Jüngst C; Berg T; Cheng J; Green RM; Jia J; Mason AL; Lammert F
    Eur J Clin Invest; 2013 Oct; 43(10):1069-83. PubMed ID: 23927644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver].
    Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A
    Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.